D. C. Cole, N. P. Govender, A. Chakrabarti, J. Sacarlal, and D. W. Denning, Improvement of fungal disease identification and management: combined health systems and public health approaches, Lancet Infect Dis, vol.17, pp.412-421, 2017.

A. Chowdhary, C. Sharma, and J. F. Meis, Azole-resistant aspergillosis: epidemiology, molecular mechanisms, and treatment, J Infect Dis, vol.216, pp.436-480, 2017.

C. Paulussen, J. E. Hallsworth, S. Alvarez-perez, W. C. Nierman, P. G. Hamill et al., Ecology of aspergillosis: insights into the pathogenic potency of Aspergillus fumigatus and some other Aspergillus species, Microb Biotechnol, vol.10, pp.296-322, 2017.

E. Zanganeh, H. Zarrinfar, F. Rezaeetalab, A. Fata, M. Tohidi et al., Predominance of non-fumigatus Aspergillus species among patients suspected to pulmonary aspergillosis in a tropical and subtropical region of the Middle East, Microb Pathog, vol.116, pp.296-300, 2018.

, Healthcare access and quality index based on mortality from causes amenable to personal health care in 195 countries and territories, 1990-2015: a novel analysis from the global burden of disease study 2015, GBD 2015 Healthcare Access and Quality Collaborators, vol.390, pp.231-66, 2017.

N. M. Ashtiani, R. Kachuei, R. Yalfani, A. B. Harchegani, and M. Nosratabadi, Identification of Aspergillus sections Flavi, Nigri, and Fumigati and their differentiation using specific primers, Infez Med, vol.25, pp.127-159, 2017.

S. J. Taj-aldeen, P. Chandra, and D. W. Denning, Burden of fungal infections in Qatar, Mycoses, vol.58, pp.51-58, 2015.

J. Wadi and D. W. Denning, Burden of serious fungal infections in Jordan, J Fungi (Basel, 2018.

S. Hilmioglu-polat, S. Seyedmousavi, M. Ilkit, M. T. Hedayati, R. Inci et al., Estimated burden of serious human fungal diseases in Turkey, Mycoses, vol.62, issue.1, pp.22-31, 2018.

M. Chekiri-talbi and D. W. Denning, Burden of fungal infections in Algeria, Eur J Clin Microbiol Infect Dis, vol.36, pp.999-1004, 2017.

A. M. Albarrag, H. M. Al-abdely, N. Khalid, and D. W. Denning, Burden of Serious Fungal Infections in Saudi Arabia

S. M. Zaki and D. W. Denning, Serious fungal infections in Egypt, Eur J Clin Microbiol Infect Dis, vol.36, pp.971-975, 2017.

R. Moghnieh, A. F. Alothman, A. O. Althaqafi, M. J. Matar, T. H. Alenazi et al., Epidemiology and outcome of invasive fungal infections and methicillinresistant Staphylococcus aureus (MRSA) pneumonia and complicated skin and soft tissue infections (cSSTI) in Lebanon and Saudi Arabia, J Infect Public Health, vol.10, pp.849-54, 2017.

S. Gheith, F. Saghrouni, W. Bannour, B. Youssef, Y. Khelif et al., In vitro susceptibility to amphotericin B, itraconazole, voriconazole, posaconazole and caspofungin of Aspergillus spp. Isolated from patients with haematological malignancies in Tunisia, SpringerPlus, vol.3, p.19, 2014.

J. Alsalman, T. Zaid, M. Makhlooq, M. Madan, Z. Mohamed et al., A retrospective study of the epidemiology and clinical manifestation of invasive aspergillosis in a major tertiary care hospital in Bahrain, J Infect Public Health, vol.10, pp.49-58, 2017.

G. E. Ozmerdiven, S. Ak, B. Ener, H. Agca, B. D. Cilo et al., First determination of azole resistance in Aspergillus fumigatus strains carrying the TR34/L98H mutations in Turkey, J Infect Chemother, vol.21, pp.581-587, 2015.

K. Haine-madani, I. Boukerzaza, and B. Hamrioui, Les otomycoses: épidémiologie et diagnostic au CHU Mustapha Bacha d'Alger, J Mycol Med, vol.23, p.210, 2013.

Y. Merad, H. Adjmi-hamoudi, K. Lahmer, E. Saadaoui, S. Cassaing et al., Les otomycoses chez les porteurs d'aides auditives: étude rétrospective de 2010 à 2015, J Mycol Med, vol.26, p.71, 2016.

M. Abdelazeem, A. Gamea, H. Mubarak, and N. Elzawawy, Epidemiology, causative agents, and risk factors affecting human otomycosis infections, Turk J Med Sci, vol.45, pp.820-826, 2015.

M. T. Ismail, A. Al-kafri, and M. Ismail, Otomycosis in Damascus, Syria: etiology and clinical features, Curr Med Mycol, vol.3, pp.27-30, 2017.

F. Al-wathiqi, S. Ahmad, and Z. Khan, Molecular identification and antifungal susceptibility profile of Aspergillus flavus isolates recovered from clinical specimens in Kuwait, BMC Infect Dis, vol.13, p.126, 2013.

K. Sarwestani, Z. Hashemi, S. J. Rezaie, S. , G. Shoar et al., Species identification and in vitro antifungal susceptibility testing of Aspergillus section Nigri strains isolated from otomycosis patients, J Mycol Med, vol.28, pp.279-84, 2018.

F. Z. Hajoui, Z. Zeroual, B. Ghfir, A. Moustachi, M. Lyagoubi et al., The mould onychomycosis in Morocco: about 150 isolated cases in 20 years, J Mycol Med, vol.22, pp.221-225, 2012.

A. H. Moubasher, A. -. Sater, M. A. Soliman, and Z. , Incidence and biodiversity of yeasts, dermatophytes and non-dermatophytes in superficial skin infections in Assiut, Egypt, J Mycol Med, vol.27, pp.166-79, 2017.

A. A. Alrajhi, M. Enani, Z. Mahasin, and K. Al-omran, Chronic invasive aspergillosis of the paranasal sinuses in immunocompetent hosts from Saudi Arabia, Am J Trop Med Hyg, vol.65, pp.83-89, 2001.

E. Erdem, M. Yagmur, H. Boral, M. Ilkit, R. Ersoz et al., Aspergillus flavus keratitis: experience of a tertiary eye clinic in Turkey, Mycopathologia, vol.182, pp.379-85, 2017.

E. Hoseinzadeh, M. R. Samarghandie, S. A. Ghiasian, M. Y. Alikhani, and G. Roshanaie, Evaluation of bioaerosols in five educational hospitals wards air in Hamedan, Jundishapur J Microbiol, vol.6, p.10704, 2011.

C. Cassagne, A. C. Normand, L. 'ollivier, C. Ranque, S. Piarroux et al., Performance of MALDI-TOF MS platforms for fungal identification, Mycoses, vol.59, pp.678-90, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01453298

P. Ramanan, N. L. Wengenack, and E. S. Theel, Laboratory diagnostics for fungal infections: a review of current and future diagnostic assays, Clin Chest Med, vol.38, pp.535-54, 2017.

M. Arvanitis, T. Anagnostou, B. B. Fuchs, A. M. Caliendo, and E. Mylonakis, Molecular and nonmolecular diagnostic methods for invasive fungal infections, Clin Microbiol Rev, vol.27, pp.490-526, 2014.

R. A. Samson, C. M. Visagie, J. Houbraken, S. B. Hong, V. Hubka et al., Phylogeny, identification and nomenclature of the genus Aspergillus, Stud Mycol, vol.78, pp.141-73, 2014.

M. V. Powers-fletcher and K. E. Hanson, Molecular diagnostic testing for Aspergillus, J Clin Microbiol, vol.54, pp.2655-60, 2016.

A. M. Albarrag, M. J. Anderson, S. J. Howard, G. D. Robson, P. A. Warn et al., Interrogation of related clinical pan-azole-resistant Aspergillus fumigatus strains: G138C, Y431C, and G434C single nucleotide polymorphisms in cyp51A, upregulation of cyp51A, and integration and activation of transposon Atf1 in the cyp51A promoter, Antimicrob Agents Chemother, vol.55, pp.5113-5134, 2011.

T. F. Patterson, G. R. Thompson-3rd, D. W. Denning, J. A. Fishman, S. Hadley et al., Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the infectious diseases society of America, Clin Infect Dis, vol.63, pp.1-60, 2016.

N. R. Stone, T. Bicanic, R. Salim, and W. Hope, Liposomal amphotericin B (AmBisome ® ): a review of the pharmacokinetics, pharmacodynamics, clinical experience and future directions, Drugs, vol.76, pp.485-500, 2016.

G. Blum, C. Hortnagl, E. Jukic, T. Erbeznik, T. Pumpel et al., New insight into amphotericin B resistance in Aspergillus terreus, Antimicrob Agents Chemother, vol.57, pp.1583-1591, 2013.

P. Chandrasekar and E. K. Manavathu, Antifungal drug resistance in Aspergillus, Antimicrobial drug resistance, pp.1099-118, 2017.

N. Ghods, M. Falahati, M. Roudbary, S. Mardani, and F. Seif, Presence of HSP90 gene in amphotericin B resistant Aspergillus species isolated from Iranian immunocompromised patients, I Infect Epidemiol Microbiol, vol.3, pp.86-95, 2017.

M. Blatzer, G. Blum, E. Jukic, W. Posch, P. Gruber et al., Blocking Hsp70 enhances the efficiency of amphotericin B treatment against resistant Aspergillus terreus strains, Antimicrob Agents Chemother, vol.59, pp.3778-88, 2015.

K. C. Gray, D. S. Palacios, I. Dailey, M. M. Endo, B. E. Uno et al., Amphotericin primarily kills yeast by simply binding ergosterol, Proc Natl Acad Sci U S A, vol.109, pp.2234-2243, 2012.

R. Garcia-rubio, L. Alcazar-fuoli, M. C. Monteiro, S. Monzon, I. Cuesta et al., Insight into the significance of Aspergillus fumigatus cyp51A polymorphisms, Antimicrob Agents Chemother, vol.62, 2018.

D. Hagiwara, A. Watanabe, K. Kamei, and G. H. Goldman, Epidemiological and genomic landscape of azole resistance mechanisms in Aspergillus Fungi, Front Microbiol, vol.7, p.1382, 2016.

S. Berger, Y. El-chazli, A. F. Babu, and A. T. Coste, Azole resistance in Aspergillus fumigatus: a consequence of antifungal use in agriculture?, Front Microbiol, vol.8, p.1024, 2017.

S. J. Howard, D. Cerar, M. J. Anderson, A. Albarrag, M. C. Fisher et al., Frequency and evolution of azole resistance in Aspergillus fumigatus associated with treatment failure, Emerg Infect Dis, vol.15, pp.1068-76, 2009.

D. Hagiwara, H. Takahashi, A. Watanabe, A. Takahashi-nakaguchi, S. Kawamoto et al., Whole-genome comparison of Aspergillus fumigatus strains serially isolated from patients with aspergillosis, J Clin Microbiol, vol.52, pp.4202-4211, 2014.

C. L. Price, J. E. Parker, A. G. Warrilow, D. E. Kelly, and S. L. Kelly, Azole fungicides -understanding resistance mechanisms in agricultural fungal pathogens, Pest Manag Sci, vol.71, pp.1054-1062, 2015.

K. Onishi, M. Sarumoh, B. Hagiwara, D. Watanabe, A. Kamei et al., Azole-resistant Aspergillus fumigatus containing a 34-bp tandem repeat in cyp51A promoter is isolated from the environment in Japan, Med Mycol J, vol.58, pp.67-70, 2017.

A. Chowdhary, C. Sharma, F. Hagen, and J. F. Meis, Exploring azole antifungal drug resistance in Aspergillus fumigatus with special reference to resistance mechanisms, Future Microbiol, vol.9, pp.697-711, 2014.

E. Snelders, S. M. Camps, A. Karawajczyk, A. J. Rijs, J. Zoll et al., Genotypephenotype complexity of the TR46/Y121F/T289A cyp51A azole resistance mechanism in Aspergillus fumigatus, Fungal Genet Biol, vol.82, pp.129-164, 2015.

C. Alvarez-moreno, R. A. Lavergne, F. Hagen, F. Morio, J. F. Meis et al., Azoleresistant Aspergillus fumigatus harboring TR34/L98H, TR46/Y121F/T289A and TR53 mutations related to flower fields in Colombia, Sci Rep, vol.7, p.45631, 2017.

A. Dudakova, B. Spiess, M. Tangwattanachuleeporn, C. Sasse, D. Buchheidt et al., Molecular tools for the detection and deduction of azole antifungal drug resistance phenotypes in Aspergillus species, Clin Microbiol Rev, vol.30, pp.1065-91, 2017.

S. Dhingra and R. A. Cramer, Regulation of sterol biosynthesis in the human fungal pathogen Aspergillus fumigatus: opportunities for therapeutic development, Front Microbiol, vol.8, p.92, 2017.

S. Camps, B. E. Dutilh, M. C. Arendrup, A. Rijs, E. Snelders et al., Discovery of a hapE mutation that causes azole resistance in Aspergillus fumigatus through whole genome sequencing and sexual crossing, PLoS One, vol.7, p.50034, 2012.

F. Gsaller, P. Hortschansky, T. Furukawa, P. D. Carr, B. Rash et al., Sterol biosynthesis and azole tolerance is governed by the opposing actions of SrbA and the CCAAT binding complex, PLoS Pathog, vol.12, p.1005775, 2016.

S. D. Willger, S. Puttikamonkul, K. Kim, J. B. Burritt, N. Grahl et al., A sterol-regulatory element binding protein is required for cell polarity, hypoxia adaptation, azole drug resistance, and virulence in Aspergillus fumigatus, PLoS Pathog, vol.4, p.1000200, 2008.

X. Wei, Y. Zhang, and L. Lu, The molecular mechanism of azole resistance in Aspergillus fumigatus: from bedside to bench and back, J Microbiol, vol.53, pp.91-100, 2015.

V. Loiko and J. Wagener, The paradoxical effect of echinocandins in Aspergillus fumigatus relies on Recovery of the beta-1,3-glucan synthase Fks1, Antimicrob Agents Chemother, p.61, 2017.

M. Campitelli, N. Zeineddine, G. Samaha, and S. Maslak, Combination antifungal therapy: a review of current data, J Clin Med Res, vol.9, pp.451-457, 2017.

N. P. Wiederhold, Antifungal resistance: current trends and future strategies to combat, Infect Drug Resist, vol.10, pp.249-59, 2017.

R. E. Gardiner, P. Souteropoulos, S. Park, and D. S. Perlin, Characterization of Aspergillus fumigatus mutants with reduced susceptibility to caspofungin, Med Mycol, vol.43, pp.299-305, 2005.

E. M. Rocha, G. Garcia-effron, S. Park, and D. S. Perlin, A Ser678Pro substitution in Fks1p confers resistance to echinocandin drugs in Aspergillus fumigatus, Antimicrob Agents Chemother, vol.51, pp.4174-4180, 2007.

R. Mansouri, S. Akil, F. Griffi, and M. C. Bentakouk, État des lieux des infections fongiques invasives au laboratoire de parasitologie mycologie du CHU d'Annaba, J Mycol Med, vol.26, p.71, 2016.

A. F. Alothman, A. O. Althaqafi, M. J. Matar, R. Moghnieh, T. H. Alenazi et al., Burden and treatment patterns of invasive fungal infections in hospitalized patients in the Middle East: real-world data from Saudi Arabia and Lebanon, Infect Drug Resist, vol.10, pp.35-41, 2017.